Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Neurodegenerative Disease > European Markets for Parkinson's Disease Therapeutics
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

European Markets for Parkinson's Disease Therapeutics

Published by Frost & Sullivan
Published May, 2009 Product code 90173
Content info 71 Pages
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


European Markets for Parkinson's Disease Therapeutics published by Frost & Sullivan in May, 2009. This report consists of 71 Pages and the price starts from US $ 6500.

Introduction

Abstract

This research service discusses the market for Parkinson' s disease. It analyses the various opportunities, recent developments, drug classes and gives a revenue forecasts.

Table of Contents

1. EXECUTIVE SUMMARY

Summary of Findings

  • Summary

2. PARKINSON' S DISEASE

Disease Overview

  • Scope
  • Overview
  • Prevalence and Incidence
  • Clinical Classification
  • Diagnosis

Treatment Overview

  • Guidelines for Parkinson' s Disease Management
  • Surgical and Related Options
  • Product and Pricing Analysis

3. MARKET FOR PARKINSON' S DISEASE THERAPEUTICS

Market Engineering Analysis

  • Market Overview
  • Market Engineering Measurements

Market Dynamics

  • Challenges
  • Market Drivers
  • Market Restraints

Market Forecasts and Trends

  • Disease Progression
  • Developments
  • Patient Forecasts
  • Revenue Forecasts

4. DOPAMINE AGONISTS MARKET

Current Drugs

  • Dosage and Pricing Analysis
  • Product Analysis

Market Dynamics

  • Market Drivers
  • Market Restraints

5. LEVODOPA/CARBIDOPA MARKET

Current Drugs

  • Dosage and Pricing Analysis
  • Product Analysis

Market Dynamics

  • Market Drivers
  • Market Restraints

6. OTHERS

Current Products and Pricing

  • COMT Inhibitors
  • MAO-B Inhibitors
  • Fixed Dose Combinations

Market Dynamics

  • Market Drivers
  • Market Restraints

Pipeline Analysis

  • Products in Phase III
  • Products in Phase II

7. DECISION SUPPORT DATABASES

List of Tables

  • Population Aged 65 Years and above
  • Female Population Aged 65 Years and above
  • Male Population Aged 65 Years and above
  • Number of Physicians
  • Hospital Discharge from Cerebrovascular Disease
Back to Top